Resource Library
We’ve compiled a useful collection of resources to learn more about Medrio and various aspects of managing your clinical trial in today’s complex and evolving environment.
          Blog        
        CDMS / EDC•eCOA / ePRO•eConsent
          Clinical Trials Medical Device Guidelines: What Sponsors Should Know
March 26, 2025
          
              Curious about medical device clinical trials? Learn tips on regulations, trial design, technology, and more!            
          
          News        
        Medrio Enhances RTSM For Faster Clinical Trial Starts and Greater Flexibility
              SAN FRANCISCO, CA – March 26, 2025—Medrio, a global leader in clinical trial technology, today announced enhancements to its randomization and trial supply management (RTSM) solution. This latest release delivers faster...            
          
          eBook        
        CDMS / EDC
          How to Run a Nimble, Cost-Effective Clinical Trial in Any Industry Climate
              Volatility is constant in clinical trials. Learn how to run a nimble, cost-effective clinical trial in any industry climate.            
          
          eBook        
        CDMS / EDC
          How to Protect Data Quality in Clinical Trials
              Bad clinical trial data can threaten market approval. Learn how to protect your data and meet standards for accuracy, consistency, and reliability.            
          
          Webinar        
        CDMS / EDC
          AI in Clinical Trials: Simplifying the Path to Insights
              Clinical trials are becoming increasingly complex, with a growing volume of data, forms, and regulations to manage. How can sponsors and CROs navigate this rising complexity while maintaining speed, quality,...            
          
          Blog        
        CDMS / EDC
          Database Lock in Clinical Trials: How to Make the Process Easier and Faster
March 3, 2025
          
              In this blog, learn field-tested tips on how to get to database lock (DBL) in clinical trials as quickly as possible.            
          




